Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Exchange Rate Effect: 2009-2025

Historic Exchange Rate Effect for Northwest Biotherapeutics (NWBO) over the last 16 years, with Sep 2025 value amounting to $3.1 million.

  • Northwest Biotherapeutics' Exchange Rate Effect rose 198.07% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 133.90%. This contributed to the annual value of $1.3 million for FY2024, which is 347.61% up from last year.
  • Northwest Biotherapeutics' Exchange Rate Effect amounted to $3.1 million in Q3 2025, which was up 178.90% from -$3.9 million recorded in Q2 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Exchange Rate Effect peaked at $4.7 million during Q3 2022, and registered a low of -$3.9 million during Q2 2025.
  • Over the past 3 years, Northwest Biotherapeutics' median Exchange Rate Effect value was -$635,000 (recorded in 2023), while the average stood at -$152,091.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 1,509.38% in 2022, then slumped by 22,952.94% in 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Exchange Rate Effect (Quarterly) stood at $462,000 in 2021, then tumbled by 706.49% to -$2.8 million in 2022, then skyrocketed by 63.95% to -$1.0 million in 2023, then spiked by 451.78% to $3.6 million in 2024, then soared by 198.07% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, -$3.9 million for Q2 2025, and -$1.6 million during Q1 2025.